FDA recommended that it grant emergency approval for a corona virus vaccine of Moderna

The US Food and Drug Administration (FDA) recommended tonight (Friday) that it grant emergency approval for a corona virus vaccine developed by a modern company. during the day. To date, the corona plague has resulted in more than 73 million infections worldwide and a death toll higher than 1.6 million.
The panel of external consultants, which convened yesterday, discussed for about eight hours a request submitted by the American pharmaceutical giant. The experts looked at the vaccine's safety and efficacy, similar to a week-long discussion about Pfizer's vaccine, which has already been given to patients in the U.S., Canada and the UK. Among those aged 18 and over.
The panel's deliberations, which included more than 20 people, including infectious disease specialists, epidemiologists and immunologists from across the U.S., were broadcast live and transparently through the Internet. Once complete approval is obtained from the FDA, the Centers for Disease Control and Prevention (CDC) is expected to give the green light to grant the vaccine to patients in the United States.
This is the second vaccine for Corona to receive FDA approval. The decision will allow millions of people in the U.S. to have access to a second vaccine as early as next week. Earlier this week, the administration announced that the modern vaccine provides strong protection against the virus, and that no serious side effects have been identified. Covid-19 disease, caused by the corona virus.
The data released this week by the FDA confirmed the pharmaceutical giant's previous estimates that the vaccine has an efficacy of 94.1%. This figure is based on the vaccine test among 30,000 volunteers. Side effects such as fever, headache or weakness caused by the vaccine, are unpleasant but also not dangerous, the administration ruled.